Ceftriaxone IM Dosing for UTI
For a urinary tract infection sensitive to ceftriaxone, administer 1-2 grams intramuscularly once daily, with the higher 2-gram dose recommended for hospitalized patients or complicated infections. 1
Dosing by Clinical Scenario
Uncomplicated Pyelonephritis (Outpatient)
- Dose: 1 gram IM once daily 2
- Frequency: Single dose or once daily
- Context: Can be used as initial long-acting parenteral therapy before transitioning to oral antibiotics, particularly when fluoroquinolone resistance exceeds 10% 2
- The 2024 European Association of Urology guidelines note that while lower doses (1g) have been studied, the higher 2-gram dose is actually recommended for optimal outcomes 1
Hospitalized Patients with Pyelonephritis
- Dose: 1-2 grams IM/IV once daily 1
- Frequency: Once daily (q.d.)
- Duration: Continue until clinical improvement, then transition to oral therapy based on susceptibilities 1
- The most recent 2024 guideline explicitly recommends the higher end of the dosing range for hospitalized patients 1
Uncomplicated Cystitis (Lower UTI)
- Dose: 500 mg IM as a single dose 3, 4
- Frequency: Single dose only
- Evidence: A single 500 mg IM dose achieved 92% cure rates in uncomplicated cystitis 3, though this is not the primary indication for ceftriaxone
Key Clinical Considerations
Route of Administration:
- IM administration is appropriate when IV access is unavailable 2
- Inject deeply into a large muscle mass with aspiration to avoid vascular injection 5
- Peak plasma concentrations occur 2-3 hours after IM injection 5
Reconstitution for IM Use:
- 1 gram vial: Add 3.6 mL diluent for 250 mg/mL concentration OR 2.1 mL for 350 mg/mL 5
- 2 gram vial: Add 7.2 mL diluent for 250 mg/mL concentration OR 4.2 mL for 350 mg/mL 5
Duration of Therapy:
- For pyelonephritis: Typically 7-14 days total (including oral step-down) 1, 2
- Recent evidence supports 3-day courses for uncomplicated UTI in hospitalized patients 6
- Continue at least 2 days after clinical improvement 5
Important Caveats
When Ceftriaxone May Not Be Optimal: While ceftriaxone is widely used for UTIs, recognize that it has lower urinary excretion rates compared to other beta-lactams like cefazolin 7. However, recent 2025 data demonstrates this does not affect clinical outcomes for pyelonephritis with bacteremia 8.
Antimicrobial Stewardship:
- Ceftriaxone carries 2.44 times higher risk of hospital-onset C. difficile infection compared to cefazolin 7
- For uncomplicated UTI in hospitalized patients, consider cefazolin as a narrower-spectrum alternative when susceptibilities allow 7
- Transition to oral therapy as soon as clinically appropriate (typically when afebrile, tolerating oral intake, and hemodynamically stable) 9
Contraindications:
- Do not use in neonates ≤28 days requiring calcium-containing IV solutions 5
- Avoid in hyperbilirubinemic neonates, especially premature infants 5
The evidence strongly supports once-daily dosing as a major advantage of ceftriaxone, improving compliance and clinical convenience 10, 11, 12. The long half-life (5.8-8.7 hours) and high protein binding make it ideal for once-daily administration 5.